Insulet | PODD - Aset Lancar





Aset Lancar Perubahan Tanggal
Abbott USD 25.51B 488M 2026-03
Align Technology USD 2.66B 7.62M 2026-06
AtriCure USD 345.53M 31.84M 2026-06
Baxter International USD 6.99B 142M 2026-06
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Boston Scientific USD 7.97B 712M 2026-06
Cardinal Health USD 38.06B 1.17B 2026-03
Cooper Companies USD 2.3B 166M 2026-03
Dexcom USD 4.09B 245.1M 2026-06
Edwards Lifesciences USD 6.82B 590.2M 2026-06
Eli Lilly USD 54.84B 794M 2026-03
Globus Medical USD 2.2B 72.51M 2026-03
ICU Medical USD 1.21B 22.69M 2026-03
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.71B 204.5M 2026-03
Integra LifeSciences USD 1.19B 19.46M 2026-06
J&J USD 59.77B 601M 2026-06
Medtronic USD 24.07B 75M 2025-12
Merit Medical Systems USD 1.11B 10.46M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Solventum Corp USD 3.58B 276M 2026-03
Stryker USD 14.42B 1.08B 2026-06
Tandem Diabetes Care USD 887.1M 268.96M 2026-03
Teleflex USD 1.86B 78.67M 2026-03
West Pharmaceutical Services USD 1.81B 19.3M 2026-06
Zimmer Biomet Holdings USD 4.96B 157.4M 2026-03